argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 682.00
+5.40 (0.80%)
Apr 10, 2026, 5:39 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €42.41 billion as of April 10, 2026. Its market cap has increased by 28.63% in one year.
Market Cap
42.41B
Enterprise Value
38.67B
Revenue
3.61B
Ranking
n/a
PE Ratio
40.92
Stock Price
€682.00
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 42.41B, an increase of 34,544.30%. That is a compound annual growth rate of 64.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 42.41B | -3.32% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.74B |
| Financière de Tubize | 9.91B |
| Onward Medical | 168.03M |
| Hyloris Pharmaceuticals | 138.04M |
| European Medical Solutions | 22.22M |
| Celyad Oncology | 14.10M |
| BioSenic | 1.57M |
| Oxurion NV | 280.39K |